Biden or Trump: How deeply will 2024’s election outcome impact pharma?

November is a long way off, but the equally anticipated and dreaded 2024 U.S. presidential election has already hit a fever pitch. With nine months to go, the major parties’ candidates appear set and the nation is off to the political races.

Between current president Joe Biden and former president Donald Trump, pharma companies find themselves between a rock and a hard place — both candidates have expressed an urge to reform the industry, although in different ways. And of course, voters are likely to respond to those desires on top of other pressing domestic and international concerns.